Do different delivery systems of hormone therapy have different effects on psychological symptoms in surgically menopausal women? A randomized controlled trial

Maturitas ◽  
2009 ◽  
Vol 62 (2) ◽  
pp. 140-145 ◽  
Author(s):  
Basak Baksu ◽  
Alparslan Baksu ◽  
Nimet Göker ◽  
S. Citak
Keyword(s):  
Randomized Controlled Trial ◽  
Hormone Therapy ◽  
Psychological Symptoms ◽  
Controlled Trial ◽  
Delivery Systems ◽  
Randomized Controlled ◽  
Menopausal Women

Effectiveness of Pilates and circuit-based exercise in reducing arthralgia in women during hormone therapy for breast cancer: a randomized, controlled trial

2021 ◽  
Author(s):  
Keyla de Paula Barbosa ◽  
Lidiane Gomes Tavares da Silva ◽  
Patrícia Azevedo Garcia ◽  
Cariele de Aguiar Freitas ◽  
Ellen Cristine Ferreira da Silva ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Randomized Controlled Trial ◽  
Hormone Therapy ◽  
Controlled Trial ◽  
Randomized Controlled

scholarly journals Equol effects on AGE skin products, visceral fat and climacteric symptoms in post-menopausal women: A randomized controlled trial

2021 ◽  
Author(s):  
Remi Yoshikata ◽  
Khin Zay Yar Myint ◽  
Hiroaki Ohta ◽  
Yoko Ishigaki
Keyword(s):  
Randomized Controlled Trial ◽  
Visceral Fat ◽  
Controlled Trial ◽  
Intervention Group ◽  
Control Group ◽  
Climacteric Symptoms ◽  
Post Intervention ◽  
Randomized Controlled ◽  
Menopausal Women ◽  
Post Menopausal

Abstract Introduction: Equol, an isoflavone derivative whose chemical structure is similar to estrogen, is considered as a potentially effective agent for relieving climacteric symptoms, for the prevention of the lifestyle-related diseases, and for aging care in post-menopausal women. We investigated the effect of an equol-containing supplement on metabolism and aging, and climacteric symptoms, with respect to internally-produced equol in post-menopausal women.Methods: A single center, randomized controlled trial (registration number: UMIN000030975) on 57 post-menopausal Japanese women (mean age: 56±5.37 years), was conducted. Twenty-seven women received the equol supplement, while the remaining received Control. Metabolic and aging-related biomarkers were compared before and after the 3-month intervention. Climacteric symptoms were assessed every month using a validated self-administered questionnaire in Japanese post-menopausal women. Results: Three months post intervention, the treatment group showed significant improvement in climacteric symptoms, when compared to the Control group (81% vs. 53% respectively, p=0.045). We did not observe any beneficial effect on metabolic and aging-related biomarkers in the intervention group. However, in certain populations significant improvement in skin auto-fluorescence, which is a measurement of AGE skin products, and visceral fat area was observed, especially among equol producers. Conclusion: Women receiving equol supplement showed improved climacteric symptoms. This study offered a new hypothesis that there may be a synergy between supplemented equol and endogenously-produced equol to improve skin aging and visceral fat in certain populations.

The Acupuncture on Hot Flushes Among Menopausal Women (ACUFLASH) study, a randomized controlled trial

2009 ◽  
Vol 16 (3) ◽  
pp. 484-493 ◽  
Author(s):  
Einar Kristian Borud ◽  
Terje Alraek ◽  
Adrian White ◽  
Vinjar Fonnebo ◽  
Anne Elise Eggen ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
Controlled Trial ◽  
Hot Flushes ◽  
Randomized Controlled ◽  
Menopausal Women

O3-01-03: Effects of hormone therapy on brain structure in recently postmenopausal women: A randomized controlled trial

2015 ◽  
Vol 11 (7S_Part_5) ◽  
pp. P217-P218
Author(s):  
Kejal Kantarci ◽  
Nirubol Tosakulwong ◽  
Timothy G. Lesnick ◽  
Samantha M. Zuk ◽  
Jeffrey L. Gunter ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
Hormone Therapy ◽  
Postmenopausal Women ◽  
Brain Structure ◽  
Controlled Trial ◽  
Randomized Controlled
Sign in / Sign up

Export Citation Format

Share Document